Literature DB >> 28384682

Interactive Voice Response-Based Self-management for Chronic Back Pain: The COPES Noninferiority Randomized Trial.

Alicia A Heapy1, Diana M Higgins2, Joseph L Goulet1, Kathryn M LaChappelle3, Mary A Driscoll1, Rebecca A Czlapinski3, Eugenia Buta4, John D Piette5, Sarah L Krein6, Robert D Kerns1.   

Abstract

Importance: Recommendations for chronic pain treatment emphasize multimodal approaches, including nonpharmacologic interventions to enhance self-management. Cognitive behavioral therapy (CBT) is an evidence-based treatment that facilitates management of chronic pain and improves outcomes, but access barriers persist. Cognitive behavioral therapy delivery assisted by health technology can obviate the need for in-person visits, but the effectiveness of this alternative to standard therapy is unknown. The Cooperative Pain Education and Self-management (COPES) trial was a randomized, noninferiority trial comparing IVR-CBT to in-person CBT for patients with chronic back pain. Objective: To assess the efficacy of interactive voice response-based CBT (IVR-CBT) relative to in-person CBT for chronic back pain. Design, Setting, and Participants: We conducted a noninferiority randomized trial in 1 Department of Veterans Affairs (VA) health care system. A total of 125 patients with chronic back pain were equally allocated to IVR-CBT (n = 62) or in-person CBT (n = 63). Interventions: Patients treated with IVR-CBT received a self-help manual and weekly prerecorded therapist feedback based on their IVR-reported activity, coping skill practice, and pain outcomes. In-person CBT included weekly, individual CBT sessions with a therapist. Participants in both conditions received IVR monitoring of pain, sleep, activity levels, and pain coping skill practice during treatment. Main Outcomes and Measures: The primary outcome was change from baseline to 3 months in unblinded patient report of average pain intensity measured by the Numeric Rating Scale (NRS). Secondary outcomes included changes in pain-related interference, physical and emotional functioning, sleep quality, and quality of life at 3, 6, and 9 months. We also examined treatment retention.
Results: Of the 125 patients (97 men, 28 women; mean [SD] age, 57.9 [11.6] years), the adjusted average reduction in NRS with IVR-CBT (-0.77) was similar to in-person CBT (-0.84), with the 95% CI for the difference between groups (-0.67 to 0.80) falling below the prespecified noninferiority margin of 1 indicating IVR-CBT is noninferior. Fifty-four patients randomized to IVR-CBT and 50 randomized to in-person CBT were included in the analysis of the primary outcome. Statistically significant improvements in physical functioning, sleep quality, and physical quality of life at 3 months relative to baseline occurred in both treatments, with no advantage for either treatment. Treatment dropout was lower in IVR-CBT with patients completing on average 2.3 (95% CI, 1.0-3.6) more sessions. Conclusions and Relevance: IVR-CBT is a low-burden alternative that can increase access to CBT for chronic pain and shows promise as a nonpharmacologic treatment option for chronic pain, with outcomes that are not inferior to in-person CBT. Trial Registration: clinicaltrials.gov Identifier: NCT01025752.

Entities:  

Mesh:

Year:  2017        PMID: 28384682      PMCID: PMC5818820          DOI: 10.1001/jamainternmed.2017.0223

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  33 in total

1.  Psychological treatments for fibromyalgia: a meta-analysis.

Authors:  Julia A Glombiewski; Alice T Sawyer; Jana Gutermann; Katharina Koenig; Winfried Rief; Stefan G Hofmann
Journal:  Pain       Date:  2010-08-19       Impact factor: 6.961

2.  Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010.

Authors:  Matthew Daubresse; Hsien-Yen Chang; Yuping Yu; Shilpa Viswanathan; Nilay D Shah; Randall S Stafford; Stefan P Kruszewski; G Caleb Alexander
Journal:  Med Care       Date:  2013-10       Impact factor: 2.983

Review 3.  Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.

Authors:  Bridget A Martell; Patrick G O'Connor; Robert D Kerns; William C Becker; Knashawn H Morales; Thomas R Kosten; David A Fiellin
Journal:  Ann Intern Med       Date:  2007-01-16       Impact factor: 25.391

4.  Meta-analysis of psychological interventions for chronic low back pain.

Authors:  Benson M Hoffman; Rebecca K Papas; David K Chatkoff; Robert D Kerns
Journal:  Health Psychol       Date:  2007-01       Impact factor: 4.267

5.  Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients.

Authors:  R C Arnau; M W Meagher; M P Norris; R Bramson
Journal:  Health Psychol       Date:  2001-03       Impact factor: 4.267

6.  A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain.

Authors:  M Roland; R Morris
Journal:  Spine (Phila Pa 1976)       Date:  1983-03       Impact factor: 3.468

Review 7.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

8.  Effect of Mindfulness-Based Stress Reduction vs Cognitive Behavioral Therapy or Usual Care on Back Pain and Functional Limitations in Adults With Chronic Low Back Pain: A Randomized Clinical Trial.

Authors:  Daniel C Cherkin; Karen J Sherman; Benjamin H Balderson; Andrea J Cook; Melissa L Anderson; Rene J Hawkes; Kelly E Hansen; Judith A Turner
Journal:  JAMA       Date:  2016 Mar 22-29       Impact factor: 56.272

9.  Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.

Authors:  Gilda Piaggio; Diana R Elbourne; Stuart J Pocock; Stephen J W Evans; Douglas G Altman
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

10.  Cooperative pain education and self-management (COPES): study design and protocol of a randomized non-inferiority trial of an interactive voice response-based self-management intervention for chronic low back pain.

Authors:  Alicia A Heapy; Diana M Higgins; Kathryn M LaChappelle; Joseph Kirlin; Joseph L Goulet; Rebecca A Czlapinski; Eugenia Buta; John D Piette; Sarah L Krein; Caroline R Richardson; Robert D Kerns
Journal:  BMC Musculoskelet Disord       Date:  2016-02-16       Impact factor: 2.362

View more
  24 in total

1.  Pediatrician Attitudes toward Digital Voice Assistant Technology Use in Clinical Practice.

Authors:  Jayme L Wilder; Devin Nadar; Nitin Gujral; Benjamin Ortiz; Robert Stevens; Faye Holder-Niles; John Lee; Jonathan M Gaffin
Journal:  Appl Clin Inform       Date:  2019-05-01       Impact factor: 2.342

2.  Effect of an interactive voice response system on self-management in kidney transplant recipients: Protocol for a randomized controlled trial.

Authors:  Raheleh Ganjali; Zhila Taherzadeh; Mahin Ghorban Sabbagh; Fatemeh Nazemiyan; Fereshteh Mamdouhi; Hamed Tabesh; Shapour Badiee Aval; Reza Golmakani; Sayyed Mostafa Mostafavi; Saeid Eslami
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.889

Review 3.  Enhancing Motivation for Change in the Management of Chronic Painful Conditions: a Review of Recent Literature.

Authors:  Brett Ankawi; Robert D Kerns; Sara N Edmond
Journal:  Curr Pain Headache Rep       Date:  2019-08-06

4.  Effects of Accessible Health Technology and Caregiver Support Posthospitalization on 30-Day Readmission Risk: A Randomized Trial.

Authors:  John D Piette; Dana Striplin; Lawrence Fisher; James E Aikens; Aaron Lee; Nicolle Marinec; Madhura Mansabdar; Jenny Chen; Lynn A Gregory; Christopher S Kim
Journal:  Jt Comm J Qual Patient Saf       Date:  2019-12-04

5.  Economic Evaluation: A Randomized Pragmatic Trial of a Primary Care-based Cognitive Behavioral Intervention for Adults Receiving Long-term Opioids for Chronic Pain.

Authors:  David H Smith; Maureen O'Keeffe-Rosetti; Michael C Leo; Meghan Mayhew; Lindsay Benes; Allison Bonifay; Richard A Deyo; Charles R Elder; Francis J Keefe; Carmit McMullen; Ashli Owen-Smith; Connie M Trinacty; William M Vollmer; Lynn DeBar
Journal:  Med Care       Date:  2022-03-30       Impact factor: 3.178

6.  Personal resource profiles of individuals with chronic pain: Sociodemographic and pain interference differences.

Authors:  Chung Jung Mun; Mary C Davis; Ivan R Molton; Paul Karoly; Hye Won Suk; Dawn M Ehde; Howard Tennen; Robert D Kerns; Mark P Jensen
Journal:  Rehabil Psychol       Date:  2019-01-28

7.  Clinical Policy Recommendations from the VHA State-of-the-Art Conference on Non-Pharmacological Approaches to Chronic Musculoskeletal Pain.

Authors:  Benjamin Kligler; Matthew J Bair; Ranjana Banerjea; Lynn DeBar; Stephen Ezeji-Okoye; Anthony Lisi; Jennifer L Murphy; Friedhelm Sandbrink; Daniel C Cherkin
Journal:  J Gen Intern Med       Date:  2018-05       Impact factor: 5.128

8.  Co-Operative Pain Education and Self-management (COPES) Expanding Treatment for Real-World Access (ExTRA): Pragmatic Trial Protocol.

Authors:  Alicia A Heapy; Mary A Driscoll; Eugenia Buta; Kathryn M LaChappelle; Sara Edmond; Sarah L Krein; John D Piette; Kristin Mattocks; Jennifer L Murphy; Lynn DeBar; R Ross MacLean; Brett Ankawi; Todd Kawecki; Steve Martino; Todd Wagner; Diana M Higgins
Journal:  Pain Med       Date:  2020-12-12       Impact factor: 3.750

Review 9.  Nonpharmacologic Treatments for Opioid Reduction in Patients With Advanced Chronic Kidney Disease.

Authors:  Carrie E Brintz; Martin D Cheatle; Laura M Dember; Alicia A Heapy; Manisha Jhamb; Amanda J Shallcross; Jennifer L Steel; Paul L Kimmel; Daniel Cukor
Journal:  Semin Nephrol       Date:  2021-01       Impact factor: 4.472

Review 10.  Telerehabilitation for Pain Management.

Authors:  Udai Nanda; Jerry Luo; Quinn Wonders; Sanjog Pangarkar
Journal:  Phys Med Rehabil Clin N Am       Date:  2021-03-06       Impact factor: 2.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.